Physician profile
Jessica B Bare
NPI 1528357209
$3,374.75
in general payments reported to CMS, 2019-2025
26 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $62.21 · 2021: $428 · 2022: $311 · 2023: $1,407 · 2024: $683 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533 · Travel and Lodging: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,533.24 |
| Travel and Lodging | $790.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,258.92 | 2023-2025 | Upsylon, Advantage System, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $325.24 | 2019-2025 | |
| Bolder Surgical LLC | $300.00 | 2021 | |
| Abbvie INC. | $217.08 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $162.53 | 2023-2024 | Veozah |
| Pfizer INC. | $153.77 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $123.14 | 2021-2025 | |
| Exact Sciences Corporation | $99.38 | 2023-2024 | Cologuard Collection Kit |
| Exeltis, USA INC. | $84.06 | 2024-2025 | Slynd |
| Intuitive Surgical, INC. | $83.17 | 2022-2023 | |
| Organon LLC | $68.43 | 2021-2024 | |
| Sage Therapeutics, LLC | $67.41 | 2024-2025 | Zurzuvae |
| Baxter Healthcare | $62.81 | 2024-2025 | Perclot, Floseal |
| Merck Sharp & Dohme LLC | $54.57 | 2019-2024 | Gardasil 9, Gardasil |
| Biohaven Pharmaceutical Holding Company LTD. | $45.52 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $37.40 | 2019-2024 | Summit Doppler |
| Sumitomo Pharma America, INC. | $36.33 | 2024 | Myfembree |
| Axonics, INC. | $34.80 | 2024 | Axonics, Bulkamid |
| Myovant Sciences INC. | $34.46 | 2021 | |
| Therapeuticsmd, INC. | $34.00 | 2019-2022 | |
| Hologic Sales and Service, LLC | $19.59 | 2024 | Acessa Provu System |
| Amag Pharmaceuticals, INC. | $18.89 | 2019 | |
| Coloplast Corp | $16.79 | 2023 | Altis |
| Medtronic, INC. | $14.40 | 2022 | |
| Lupin INC. | $11.16 | 2019 | |
| Olympus America INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Bare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.